top of page

Search Results

229 results found for "new jersey"

  • Health Inequity: Barriers Caused by Abusive Payer Practices

    The barriers caused by abusive payer practices is nothing new to patients living with chronic health Similarly, the New York Timescovered the issue of payers refusing to cover the cost of high-cost, life-saving entities responsible for McNaughton’s experiences, or those described by the numerous patients included in New Indeed, MCOs and private payers have a history of refusing to add new medications to formularies, arguing The New York Times piece notably reminds readers, when payers or even government officials argue for

  • Mixed Signals - Trump's Drug Policy Undermines Its Own Goals

    Last week, STAT Newsobtained the Trump administration's new drug policy statement, revealing a contradictory Understanding the New Policy Document The Trump Administration's drug policy document sets out six key writing a blog post cautioning against the "temptation to develop seemingly quick solutions," this new In New Hampshire, 82% of Medicaid enrollees with opioid use disorder receive medication-assisted treatment Carter, a Fox News contributor with no background in drug policy, public health, or government, would

  • Innovation as a Change Agent for Patients Leaving Incarceration

    But thanks to a program at the New Orleans jail, Dontrace is now equipped with Narcan and the knowledge However, two innovative programs – one in New Orleans and one in Connecticut – offer a different approach Overdose Prevention: Preparing for Reentry in New Orleans Inside the walls of the Orleans Justice Center As a 2007 study in the New England Journal of Medicine revealed, the risk of overdose is 129 times higher Redefining Innovation: Lessons from the Margins The programs in New Orleans and Connecticut offer a powerful

  • Patients Still at Risk - The State of Copay Accumulator Adjustment Policies in 2025

    The court declared that insurers must follow the more protective 2020 rule until HHS issues new regulations far declined to enforce the 2020 rule, instead announcing plans to update the cost-sharing rule with new toward patients' deductibles and out-of-pocket limits: Connecticut, Delaware, Illinois, Louisiana, New Mexico, New York, Oklahoma, Virginia, and West Virginia. The New Administration's Position and FTC Scrutiny The Trump administration has signaled that PBM reform

  • World AIDS Day - The Resistance of Resilience

    This ability to adapt—to find new paths when old ones are blocked—is one of our greatest strengths. This year’s uncertainties are not new terrain. Funding threats today can become new opportunities tomorrow—but only if we keep momentum alive.

  • Misinformation: An Ever-Growing Public Health Threat

    Within mere hours after the shooting made national news and before even the full count of children murdered These actions have already resulted in a trans woman being assaulted in Texas.This isn’t new. there are people willing to consider these nonsensical leaps as valid possibilities.None of this is new

  • Biden Drug Policy Agenda: NIH Invests in Harm Reduction

    On December 29th, 2021, the National Institute of Health (NIH) issued two new requests for application The idea the NIH proposes is to develop and test new harm reduction strategies, examining the efficacy existing harm reduction models, effective implementation of harm reduction strategies, and examining new

  • Criminal Counterfeits Threaten Patient Safety

    In February 2021, a patient in New York City opened a sealed bottle of the HIV drug Biktarvy, took his at a discount to other co-conspirators running distribution companies in Mississippi, Maryland, and New years of the HIV/AIDS epidemic pooled resources to share medicines with those who could not access new

  • European Commission Approves Once Every 6 Month Supplemental HIV-Treatment

    a decision from the United States’ Food and Drug Administration (FDA) on its recently resubmitted “New This is one of the final steps in an initial new drug approval.

  • The Coming HIV Care Crisis

    and Virginia face 21% spending cuts over the 10-year period, while Southern states that bear 52% of new The region accounts for 52% of new diagnoses, and includes many non-expansion states where 66% of HIV-positive Responsibility The legislation represents fiscal malpractice when considering the long-term costs of new Each new HIV infection creates $501,000 in lifetime healthcare costs, while achieving 72% viral suppression The math is unambiguous: preventing new infections through sustained treatment is far more cost-effective

  • Potentially Powerful Tools: A Vaccine in the Fight Against HCV

    Both new mRNA and viral vector vaccines, used in the COVID-19 vaccines currently authorized by the Food With “anti-vax” sentiments rising at exceptional rates, especially associated with “new” technologies

  • Ongoing Viral Hepatitis Outbreaks: Systemic Interventions

    Viral Hepatitis outbreaks, namely Hepatitis A and Hepatitis B, have been in the news quite a bit during Mark levin, said the state had been anticipating an eventual outbreak because of existing outbreaks in New

bottom of page